HORMONE-RESISTANT PROSTATE CANCER
Clinical trials for HORMONE-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug shows promise for Tough-to-Treat prostate cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab can help men with advanced prostate cancer that has stopped responding to the hormone therapy enzalutamide. About 58 men whose cancer continued to grow despite enzalutamide will receive pembrolizumab. The main g…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Diet before chemo may cut side effects in cancer patients
Symptom relief OngoingThis study tests whether eating a low-calorie diet before chemotherapy can reduce side effects like fatigue, nausea, and mouth sores, and also improve how well the treatment works. About 130 adults with breast or prostate cancer will follow either a controlled low-calorie diet or…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
Gene hunt in prostate cancer: can DNA clues improve treatment?
Knowledge-focused OngoingThis study is for men with prostate cancer that has spread and is no longer responding to hormone therapy. Researchers collect tissue, blood, and urine samples to study gene changes and look for biomarkers. The goal is to better understand how the cancer behaves and how patients …
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 05:31 UTC